Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	inclusion criteria: * relapsing multiple sclerosis (rms) diagnosis * eligible for ofatumumab treatment * willing and eligible to receive sars-cov-2 mrna vaccine	inclusion criteria: * relapsing multiple sclerosis (rms) diagnosis * eligible for ofatumumab treatment * willing and eligible to receive sars-cov-2 mrna vaccine
May 8, 2021, 12:31 a.m.	usa	inclusion criteria: - relapsing multiple sclerosis (rms) diagnosis - eligible for ofatumumab treatment - willing and eligible to receive sars-cov-2 mrna vaccine	inclusion criteria: - relapsing multiple sclerosis (rms) diagnosis - eligible for ofatumumab treatment - willing and eligible to receive sars-cov-2 mrna vaccine
May 5, 2021, 11:25 a.m.	usa	inclusion criteria: - relapsing multiple sclerosis (rms) diagnosis - eligible for ofatumumab treatment - willing and eligible to recieve sars-cov-2 mrna vaccine	inclusion criteria: - relapsing multiple sclerosis (rms) diagnosis - eligible for ofatumumab treatment - willing and eligible to recieve sars-cov-2 mrna vaccine